1 December 2023
- 22:1122:11, 1 December 2023 diff hist +25 University Cancer Institute Toulouse-Oncopole →Trials (University Cancer Institute Toulouse-Oncopole)
- 22:1022:10, 1 December 2023 diff hist +57,425 N Trials (University Cancer Institute Toulouse-Oncopole) Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to University Cancer Institute Toulouse-Oncopole page '''NCTID''': NCT06112314 '''Title''': IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) '''Study Summary''': This is a phase 3, randomized, controlled study of IMC-F106C plus nivolumab compared to standard nivolumab regimens in HLA-A*02:01-positive participants with previously untreated advanced mel..."
- 22:0922:09, 1 December 2023 diff hist −5 University Cancer Institute Toulouse-Oncopole →Trials
- 22:0822:08, 1 December 2023 diff hist +62 Resources: Wellness treatments (Institut Paoli-Calmettes) No edit summary
- 22:0822:08, 1 December 2023 diff hist +62 Resources: Trials List (Institut Paoli-Calmettes) No edit summary
- 22:0722:07, 1 December 2023 diff hist +62 Novel Therapies and Diagnostic Methods (Institut Paoli-Calmettes) No edit summary
- 22:0722:07, 1 December 2023 diff hist +63 Training: Specialized Training in Oncology (DESC) (Institut Paoli-Calmettes) No edit summary
- 22:0722:07, 1 December 2023 diff hist +63 Training: Specialized Trainings (DESU, DESIU, DU, IUD, AND CU) (Institut Paoli-Calmettes) No edit summary
- 22:0622:06, 1 December 2023 diff hist +63 Training: Master in Health Biology (Institut Paoli-Calmettes) No edit summary
- 22:0622:06, 1 December 2023 diff hist +63 Experts (Institut Paoli-Calmettes) No edit summary
- 22:0522:05, 1 December 2023 diff hist +25 Institut Paoli-Calmettes →Trials (Institut Paoli-Calmettes)
- 22:0422:04, 1 December 2023 diff hist +268,373 N Trials (Institut Paoli-Calmettes) Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut Paoli-Calmettes page '''NCTID''': NCT04070443 '''Title''': Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase '''Study Summary''': The investigators hypothesize that, in newly diagnosed de novo chronic phase CML patients, an induction treatment with ponatinib for 6 months should increase the rate of patients reaching a stable..."
- 22:0322:03, 1 December 2023 diff hist −88 Institut Paoli-Calmettes →Trials
- 22:0222:02, 1 December 2023 diff hist +52 Resource: Trials List (Institut Curie) No edit summary
- 22:0222:02, 1 December 2023 diff hist +52 Associations List (Institut Curie) No edit summary
- 22:0222:02, 1 December 2023 diff hist +52 Novel Therapies and Diagnostic Methods (Institut Curie) No edit summary
- 22:0122:01, 1 December 2023 diff hist +53 Training: Scientific Training (Institut Curie) No edit summary
- 22:0122:01, 1 December 2023 diff hist +72 Course: University Diplomas and Inter-university Diplomas (Institut Curie) No edit summary
- 22:0022:00, 1 December 2023 diff hist +53 Course: Technical and Generalist Courses (Institut Curie) No edit summary
- 22:0022:00, 1 December 2023 diff hist +53 Course: International Courses (Institut Curie) No edit summary
- 22:0022:00, 1 December 2023 diff hist +53 Experts (Institut Curie) No edit summary
- 21:5921:59, 1 December 2023 diff hist +25 Institut Curie →Trials (Institut Curie)
- 21:5821:58, 1 December 2023 diff hist +73,069 N Trials (Institut Curie) Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut Curie page '''NCTID''': NCT03875573 '''Title''': Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer: '''Study Summary''': Neo-CheckRay is a multicenter, open-label phase II study that randomizes luminal B breast cancer subjects candidate for neo-adjuvant chemotherapy in a 1:1:1 ratio in 3 arms:..."
- 21:5721:57, 1 December 2023 diff hist −88 Institut Curie →Trials
- 21:5721:57, 1 December 2023 diff hist +58 Resource: Therapeutic Education For Patients and Relatives (ETAPP) (Léon Bérard Center) No edit summary
- 21:5621:56, 1 December 2023 diff hist +58 Resource: Take Care of Yourself (Léon Bérard Center) No edit summary
- 21:5621:56, 1 December 2023 diff hist +58 Resource: Oncogenetics Consultation (Léon Bérard Center) No edit summary
- 21:5621:56, 1 December 2023 diff hist +58 Resource: Occupational Cancer Consultation (Léon Bérard Center) No edit summary
- 21:5621:56, 1 December 2023 diff hist +58 Resource: Addiction Treatment (Léon Bérard Center) No edit summary
- 21:5521:55, 1 December 2023 diff hist +58 Resource: Adaptive Physical Activity (Léon Bérard Center) No edit summary
- 21:5521:55, 1 December 2023 diff hist +58 Patient Association: The Léon Bérard Center Volunteers Association (Léon Bérard Center) No edit summary
- 21:5521:55, 1 December 2023 diff hist +58 Facility: Espace de Rencontres et d Information (ERI) (Léon Bérard Center) No edit summary
- 21:5521:55, 1 December 2023 diff hist +58 Novel Therapies and Diagnostic Methods (Léon Bérard Center) No edit summary
- 21:5421:54, 1 December 2023 diff hist +59 Courses: University Courses Compilation (Léon Bérard Center) No edit summary
- 21:5421:54, 1 December 2023 diff hist +59 Trainings: Trainings Institute Compilation (Léon Bérard Center) No edit summary
- 21:5321:53, 1 December 2023 diff hist +59 Experts (Léon Bérard Center) No edit summary
- 21:5221:52, 1 December 2023 diff hist +25 Léon Bérard Center →Trials (Léon Bérard Center)
- 21:5221:52, 1 December 2023 diff hist +131,590 N Trials (Léon Bérard Center) Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Léon Bérard Center page '''NCTID''': NCT01222767 '''Title''': Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy '''Study Summary''': This is a phase II Multicenter, Open-label, Clinical and Pharmacokinetic Study of Zalypsis® (PM00104) in Patients with Unresectable Loc..."
- 21:5121:51, 1 December 2023 diff hist −81 Léon Bérard Center →Trials
- 21:4421:44, 1 December 2023 diff hist +64 Quality of Life and Palliative Care Research (France) No edit summary
- 21:4321:43, 1 December 2023 diff hist −46 Patient Guides: ESMO Patient Guides Compilation (France) No edit summary
- 21:4321:43, 1 December 2023 diff hist −42 Patient Association: Lyonnes de Tatooine (France) No edit summary
- 21:4321:43, 1 December 2023 diff hist −12 Patient Association: HOPE (France) No edit summary
- 21:4321:43, 1 December 2023 diff hist −16 Patient Association: CERHOM (France) No edit summary
- 21:4221:42, 1 December 2023 diff hist −24 Patient Association: On est là (France) No edit summary
- 21:4221:42, 1 December 2023 diff hist −16 Patient Association: JAMALV (France) No edit summary
- 21:4221:42, 1 December 2023 diff hist −38 Patient Association: Europa Donna Lyon (France) No edit summary
- 21:4221:42, 1 December 2023 diff hist −40 Patient Association: Mon Réseau Cancer (France) No edit summary
- 21:4221:42, 1 December 2023 diff hist −186 Patient Association: Le Comité du Rhône de la Ligue nationale contre le cancer et les comités départementaux (France) No edit summary
- 21:4121:41, 1 December 2023 diff hist −26 Patient Association: HNPCC Lynch (France) No edit summary
